Neurologic toxicities of cancer therapies

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Current Neurology and Neuroscience Reports

• Publication date

  2006-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/S11910-006-0009-8PMID 16635431
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Randomized, Double-Blinded, Placebo-Controlled Phase II Trial of Recombinant Human Leukemia Inhibitory Factor (rhuLIF, Emfilermin, AM424) to Prevent Chemotherapy-Induced Peripheral Neuropathy

  2005cited by this paper
• Oxaliplatin‐induced neurotoxicity and the development of neuropathy

  2005influential reference
• Myelopathy Due to Intrathecal Chemotherapy: Report of Six Cases

  2005cited by this paper
• Diffusion-weighted MR imaging of early methotrexate-related neurotoxicity in children.

  2005cited by this paper
• Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer

  2005cited by this paper
• Severe Encephalopathy Induced by the First but Not the Second Course of High-Dose Methotrexate Mirrored by Plasma Homocysteine Elevations and Preceded by Extreme Differences in Pretreatment Plasma Folate

  2005cited by this paper
• A quantitative MR imaging assessment of leukoencephalopathy in children treated for acute lymphoblastic leukemia without irradiation.

  2005cited by this paper
• Imaging changes and cognitive outcome in primary CNS lymphoma after enhanced chemotherapy delivery.

  2005cited by this paper
• Neurological toxicity of long‐term (>1 yr) thalidomide therapy in patients with multiple myeloma

  2005cited by this paper
• Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine.

  2005cited by this paper
• MTX-induced white matter changes are associated with polymorphisms of methionine metabolism

  2005cited by this paper
• Neuroprotection with amifostine in the first-line treatment of advanced ovarian cancer with carboplatin/paclitaxel-based chemotherapy—a double-blind, placebo-controlled, randomized phase II study from the Arbeitsgemeinschaft Gynäkologische Onkologoie (AGO) Ovarian Cancer Study Group

  2005cited by this paper
• Role of GSTM1, GSTP1, and GSTT1 Gene Polymorphism in Ifosfamide Metabolism Affecting Neurotoxicity and Nephrotoxicity in Children

  2005cited by this paper
• Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRI

  2005cited by this paper
• A Pilot Study on the Effect of Acetyl-L-Carnitine in Paclitaxel-And Cisplatin-Induced Peripheral Neuropathy

  2005cited by this paper
• Oxaliplatin causes selective atrophy of a subpopulation of dorsal root ganglion neurons without inducing cell loss

  2005cited by this paper
• Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage‐gated sodium channels

  2005cited by this paper
• Cognitive Changes in Children Treated for Acute Lymphoblastic Leukemia With Chemotherapy Only According to the Pediatric Oncology Group 9605 Protocol

  2005cited by this paper
• Oxaliplatin-Associated Neuropathy: A Review

  2005cited by this paper
• Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study

  2004cited by this paper
• Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome.

  2004influential reference
• MRI morphometric and neuropsychological correlates of long‐term memory in survivors of childhood leukemia

  2004cited by this paper
• Prevention of Oxaliplatin-Related Neurotoxicity by Calcium and Magnesium Infusions

  2004cited by this paper
• Cognitive functions in survivors of primary central nervous system lymphoma

  2004cited by this paper
• Neurophysiological Study of Peripheral Neuropathy after High-Dose Paclitaxel

  2004cited by this paper
• Acute neurotoxicity in children with advanced stage B-non-Hodgkin's lymphoma and B-acute lymphoblastic leukaemia treated with the United Kingdom children cancer study group 9002/9003 protocols.

  2004cited by this paper
• Neurophysiological Evaluation of Late Effects of Adjuvant High-dose Chemotherapy on Cognitive Function

  2004cited by this paper
• Severe complications after intrathecal methotrexate (MTX) for treatment of primary central nervous system lymphoma (PCNSL).

  2004cited by this paper
• Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy.

  2004cited by this paper
• Low-Dose Thalidomide for Multiple Myeloma: Interim Analysis of a Compassionate Use Program

  2004cited by this paper
• Thalidomide neurotoxicity

  2004cited by this paper
• Amifostine protects against chemotherapy-induced neurotoxicity: an in vitro investigation.

  2004cited by this paper
• Oxaliplatin‐induced neurotoxicity: Acute hyperexcitability and chronic neuropathy

  2004cited by this paper
• Thalidomide neuropathy: clinical, electrophysiological and neuroradiological features

  2004influential reference
• Diffusion-weighted MRIs in an acute leukoencephalopathy following intrathecal chemotherapy

  2004cited by this paper
• The cognitive sequelae of standard‐dose adjuvant chemotherapy in women with breast carcinoma

  2004cited by this paper
• Narrowing of the critical region in autosomal recessive spastic paraplegia linked to the SPG5 locus

  2004cited by this paper
• Cognitive status and quality of life after treatment for primary CNS lymphoma

  2004cited by this paper
• Treatment-induced leukoencephalopathy in primary CNS lymphoma

  2004cited by this paper
• Methylene blue reversal of ifosfamide-related encephalopathy.

  2004cited by this paper
• Fatal Acute Encephalomyelitis After a Single Dose of Intrathecal Methotrexate

  2004cited by this paper
• Incidence and severity of ifosfamide-induced encephalopathy

  2004influential reference
• Ifosfamide-induced encephalopathy with or without using methylene blue

  2004cited by this paper
• Thalidomide sensory neurotoxicity

  2004cited by this paper
• White matter and cerebral metabolite changes in children undergoing treatment for acute lymphoblastic leukemia: longitudinal study with MR imaging and 1H MR spectroscopy.

  2003cited by this paper
• Randomized double-blind trial of combined modality treatment with or without amifostine in unresectable stage III non-small-cell lung cancer.

  2003cited by this paper
• MRI in methotrexate-related leukoencephalopathy: Disseminated necrotising leukoencephalopathy in comparison with mild leukoencephalopathy

  2003cited by this paper
• Assessment of the protective effects of amifostine against cisplatin-induced toxicity.

  2003cited by this paper
• Thalidomide-induced neuropathy: A ganglionopathy?

  2003cited by this paper
• Cytosine arabinofuranoside-induced activation of astrocytes increases the susceptibility of neurons to glutamate due to the release of soluble factors.

  2003cited by this paper
• Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients.

  2003influential reference
• Neurological Toxicity of Ifosfamide

  2003cited by this paper
• Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.

  2003cited by this paper
• Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia.

  2003cited by this paper
• Phase II randomized trial of cisplatin and WR-2721 versus cisplatin alone for metastatic melanoma: an Eastern Cooperative Oncology Group Study (E1686)

  2003cited by this paper
• Methylene blue for the treatment and prophylaxis of ifosfamide-induced encephalopathy.

  2003cited by this paper
• Cerebellitis in an adult with abnormal magnetic resonance imaging findings prior to the onset of ataxia.

  2003cited by this paper
• Limited access trial using amifostine for protection against cisplatin- and three-hour paclitaxel-induced neurotoxicity: a phase II study of the Gynecologic Oncology Group.

  2003cited by this paper
• Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma.

  2003cited by this paper
• Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07.

  2003cited by this paper
• Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.

  2003cited by this paper
• Amifostine before chemotherapy: improved tolerance profile of the subcutaneous over the intravenous route.

  2003cited by this paper
• Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine.

  2003cited by this paper
• Acute oxaliplatin-induced peripheral nerve hyperexcitability.

  2002cited by this paper
• Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer.

  2002influential reference
• Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate.

  2002cited by this paper
• Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor.

  2002cited by this paper
• Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

  2002influential reference
• Methotrexate‐Induced Toxic Leukoencephalopathy

  2002cited by this paper
• Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients.

  2002cited by this paper
• DEXTROMETHORPHAN IS EFFECTIVE IN THE TREATMENT OF SUBACUTE METHOTREXATE NEUROTOXICITY

  2002cited by this paper
• Slight cognitive impairment and magnetic resonance imaging abnormalities but normal school levels in children treated for acute lymphoblastic leukemia with chemotherapy only.

  2001cited by this paper
• Oxidative stress mediates neuronal DNA damage and apoptosis in response to cytosine arabinoside

  2001cited by this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Ifosfamide and its Metabolites

  2001cited by this paper
• Reversal of neurologic disturbances related to high-dose methotrexate by aminophylline.

  2001cited by this paper
• A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels.

  2001cited by this paper
• The experimental neuroprotectant leukaemia inhibitory factor (LIF) does not compromise antitumour activity of paclitaxel, cisplatin and carboplatin

  2001cited by this paper
• Subcutaneous administration of amifostine: a promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy.

  2001cited by this paper
• Cognitive function in breast cancer patients receiving adjuvant chemotherapy.

  2000cited by this paper
• White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings.

  2000cited by this paper
• Patients treated with antitumor drugs displaying neurological deficits are characterized by a low circulating level of nerve growth factor.

  2000cited by this paper
• Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature

  2000cited by this paper
• Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma.

  2000cited by this paper
• Evidence that nerve growth factor promotes the recovery of peripheral neuropathy induced in mice by cisplatin: behavioral, structural and biochemical analysis.

  2000cited by this paper
• The mechanism of Ara‐C‐induced apoptosis of differentiating cerebellar granule neurons

  1999cited by this paper
• Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats.

  1999cited by this paper
• Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

  1998influential reference

• Kinin B1 and B2 Receptors: Role in Tumor Progression and Pain Associated With Tumor and Anticancer Therapy.

  2025cites this paper
• The Effect of Endurance Training on Oxidative Stress Markers in the Brain Tissue of Rats Under Cisplatin

  2025cites this paper
• Headache Management in Individuals with Brain Tumor

  2024cites this paper
• Cancer-associated cachexia — understanding the tumour macroenvironment and microenvironment to improve management

  2023cites this paper
• Methotrexate-Induced Neurotoxicity in Paediatric Malignancies

  2022influential citation
• Anticancer and Neuroprotective Activities of Ethyl Acetate Fractions from Morus macroura Miq. Plant Organs with Ultraperformance Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry Profiling

  2022cites this paper
• Chemotherapy-Induced Leukoencephalopathy: A Case Series

  2021influential citation
• The effect of some natural antioxidants against cisplatin-induced neurotoxicity in rats: behavioral testing

  2020cites this paper
• Neurological Complications of Chemotherapy

  2019cites this paper
• Estudio metaanalítico de la efectividad de los tratamientos farmacológicos y no farmacológicos en la neuropatía periférica inducida por quimioterapia

  2019cites this paper
• Cytarabine and Ferric Carboxymaltose (Fe+3) Increase Oxidative Damage and Alter Serotonergic Metabolism in Brain.

  2019cites this paper
• Neurological Complications of Chemotherapy

  2018cites this paper
• Neurotoxicity of cytarabine (Ara‐C) in dorsal root ganglion neurons originates from impediment of mtDNA synthesis and compromise of mitochondrial function

  2018cites this paper
• Cancer Neurology in Clinical Practice

  2018cites this paper
• Neuroprotective effect of nebivolol against cisplatin‐associated depressive‐like behavior in rats

  2017cites this paper
• A Case of Subacute Encephalopathy Developing After Treatment With Clofarabine and Methotrexate That Resolved With Corticosteroids.

  2016cites this paper
• Oleic Acid Protects Against Oxidative Stress Exacerbated by Cytarabine and Doxorubicin in Rat Brain.

  2016cites this paper
• A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies

  2015cites this paper
• Development of new therapeutic approaches in mouse models of Amyotrophic Lateral Sclerosis

  2015cites this paper
• Platinum-based chemotherapy: gastrointestinal immunomodulation and enteric nervous system toxicity.

  2015cites this paper
• Kinetics and mechanistic investigation into the possible activation of imidazolium trans-[tetrachloridodimethylsulfoxideimidazoleruthenate(III)], NAMI-A, by 2-mercaptoethane sulfonate.

  2014cites this paper
• Neurological adverse drug reactions of anticancer drugs

  2014cites this paper
• Mirtazapine protects against cisplatin‐induced oxidative stress and DNA damage in the rat brain

  2013cites this paper
• The Lived Experience of Peripheral Neuropathy after Solid Organ Transplant

  2012cites this paper
• Impact of oxaliplatin-induced neuropathy: a patient perspective

  2012cites this paper
• Infectious, metabolic, and endocrine complications.

  2012cites this paper
• Neurological complications of chemotherapy to the central nervous system.

  2012cites this paper
• Toxic encephalopathy in elderly patients during treatment with capecitabine: literature review and a case report

  2011cites this paper
• A review of the logistic role of l‐carnitine in the management of radiation toxicity and radiotherapy side effects

  2011cites this paper
• Nicotinamide Inhibits Alkylating Agent-Induced Apoptotic Neurodegeneration in the Developing Rat Brain

  2011cites this paper
• The developmental neurotoxicity study of platinum compounds. Effects of cisplatin versus a novel Pt(II) complex on rat cerebellum.

  2011cites this paper
• Cytotoxic chemotherapy-induced odontalgia: a differential diagnosis for dental pain.

  2010cites this paper
• Mesial temporal sclerosis associated with methotrexate-induced leukoencephalopathy.

  2009cites this paper
• Onkologie und Nervensystem

  2009cites this paper
• Methylene blue in place of acridine orange as a photosensitizer in photodynamic therapy of osteosarcoma.

  2008cites this paper
• The side effects of chemotherapeutic agents

  2008cites this paper
• Cytosine arabinoside affects the heat and capsaicin receptor TRPV1 localisation and sensitivity in human sensory neurons

  2008cites this paper
• Protection of ionizing radiation-induced cytogenetic damage by hydroalcoholic extract of Cynodon dactylon in Chinese hamster lung fibroblast cells and human peripheral blood lymphocytes.

  2008cites this paper
• Anti-cancer drug induced neurotoxicity and identification of Rho pathway signaling modulators as potential neuroprotectants.

  2008cites this paper
• A high-dose bortezomib neuropathy with sensory ataxia and myelin involvement.

  2007cites this paper
• Barriers to pain management in the rehabilitation of the surgical oncology patient

  2007cites this paper
• The role of saliva in oral health: strategies for prevention and management of xerostomia.

  2007cites this paper
• Indexed in Embase/excerpta Medica/elsevier Biobase Krause & Pachernegg Gmbh . Verlag Für Medizin Und Wirtschaft . A-3003 Gablitz Online-datenbank Mit Autoren-und Stichwortsuche

  year unknowncites this paper